OPKO Health to Report Second Quarter 2022 Financial Results on August 4, 2022

Rhea-AI Summary

OPKO Health (NASDAQ: OPK) will report its operating and financial results for Q2 2022 on August 4, 2022, after U.S. markets close. The company will hold a conference call at 4:30 p.m. Eastern Time to discuss these results and provide financial guidance. Investors are encouraged to pre-register for easier access to the call. A replay of the conference call will be available until August 11, 2022. OPKO is focused on establishing industry-leading positions in rapidly growing markets through its innovative biopharmaceutical and diagnostics expertise.

Positive

• Scheduled conference call for financial results may enhance transparency with investors.
• Potential for positive financial guidance during the upcoming call.

Negative

• None.

MIAMI, July 25, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2022 after the close of the U.S. financial markets on Thursday, August 4, 2022. OPKO’s senior management will provide a business update and discuss financial results as well as financial guidance during a conference call and live audio webcast on August 4^th beginning at 4:30 p.m. Eastern time.

CONFERENCE CALL & WEBCAST INFORMATION

OPKO encourages participants to pre-register for the conference call using this link. Callers who pre-register will be given a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing (833) 630-0584 (U.S.) or (412) 317-1815 (International). A webcast of the call may also be accessed at OPKO’s Investor Relations page and here.

A telephone replay will be available until August 11, 2022 by dialing (877) 344-7529 (U.S.) or (412) 317-0088 (International) and providing the passcode 5775821. A webcast replay will be available beginning approximately one hour after the completion of the live conference call here.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.

Contacts:

LHA Investor Relations
Yvonne Briggs, 310-691-7100
ybriggs@lhai.com 
or
Bruce Voss, 310-691-7100
bvoss@lhai.com 

FAQ

When will OPKO Health report its Q2 2022 financial results?

OPKO Health will report its Q2 2022 financial results on August 4, 2022.

What time is the OPKO Health conference call?

The OPKO Health conference call is scheduled for 4:30 p.m. Eastern Time on August 4, 2022.

How can I access the OPKO Health conference call?

Participants can pre-register for the call or dial in at (833) 630-0584 (U.S.) or (412) 317-1815 (International).

Is there a replay available for the OPKO Health conference call?

Yes, a telephone replay will be available until August 11, 2022.

What is the focus of OPKO Health as a company?

OPKO Health focuses on establishing industry-leading positions in biopharmaceutical and diagnostics markets.